Shopping Cart
- Remove All
![TargetMol](https://www.targetmol.com/storage/error/oops.webp)
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Gallinamide A TFA is a peptide that exhibits linear deposition and serves as a potent inhibitor of cathepsin L (CatL) with an IC50 of 17.6 pM. It inhibits SARS-CoV-2 infection by targeting CatL (EC50: 28 nM) and also inhibits Plasmodium falciparum with an IC50 of 50 nM [1] [2]. |
In vitro | Gallinamide A TFA exhibits low cytotoxicity, with a CC₅₀ of over 100 μM in VeroE6 cells. At a concentration of 0.5 μM for 96 hours, Gallinamide A TFA can inhibit CatL-mediated endosomal entry of SARS-CoV-2 into VeroE6 cells [1]. This compound also shows synergistic effects with the TMPRSS2 inhibitor Nafamostat mesylate, demonstrating effective antiviral activity in HEK-ACE2-TMPRSS2 cells but is ineffective in the VeroE6 cell line [1]. |
Molecular Weight | 706.79 |
Formula | C33H53F3N4O9 |
Cas No. | 1352920-57-0 |
Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 6 months | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.